Atlas Trials

Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients

Clinical trial NCT01481272 · COMPLETED

Trial details

NCT number
NCT01481272
Sponsor
Polish Lymphoma Research Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diffuse Large B Cell Lymphoma
Start date
2011-11-01
Primary completion
2017-07-01
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.